+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Addiction Disorders Drugs Market Research Reports

Opioid Use Disorder (OUD) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Opioid Use Disorder (OUD) - Epidemiology Forecast - 2032

  • Report
  • July 2023
  • 67 Pages
  • Global
From
From
From
From
From
Alcohol Addiction - Pipeline Insight, 2024 - Product Thumbnail Image

Alcohol Addiction - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Opioid Overdose - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid Overdose - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Smoking Cessation and Nicotine Deaddiction - Pipeline Insight, 2024 - Product Thumbnail Image

Smoking Cessation and Nicotine Deaddiction - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Substance (Drug) Abuse - Pipeline Insight, 2024 - Product Thumbnail Image

Substance (Drug) Abuse - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Nicotine Addiction - Pipeline Insight, 2024 - Product Thumbnail Image

Nicotine Addiction - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Opioid Dependence - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid Dependence - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Cocaine Use Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Cocaine Use Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Opioid related disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid related disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Non-Opioid Strontium Chloride - Pipeline Insight, 2024 - Product Thumbnail Image

Non-Opioid Strontium Chloride - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Opioid-Induced Constipation - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid-Induced Constipation - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cannabis-Use-Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Cannabis-Use-Disorder - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Substance Use Disorder (SUD) - Pipeline Insight, 2024 - Product Thumbnail Image

Substance Use Disorder (SUD) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Alcohol Use Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Alcohol Use Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
Narcotic Overdose - Pipeline Insight, 2024 - Product Thumbnail Image

Narcotic Overdose - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cocaine Intoxication - Epidemiology Forecast - 2034 - Product Thumbnail Image

Cocaine Intoxication - Epidemiology Forecast - 2034

  • Report
  • April 2024
  • 47 Pages
  • Global
From
Loading Indicator

The Addiction Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs used to treat addiction disorders. These drugs are used to treat a variety of conditions, including alcohol and drug addiction, nicotine addiction, and gambling addiction. The market is composed of both generic and branded drugs, with the latter being more expensive. The market is highly competitive, with many companies vying for market share. Companies in the market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, and Sanofi. These companies are constantly researching and developing new drugs to treat addiction disorders, as well as improving existing treatments. Additionally, many of these companies are involved in clinical trials to test the efficacy of their drugs. Show Less Read more